incretin mimetic agents glp 1 receptor agonists GLP-1s & Beyond: Understanding Opportunities GLP-1 and the kidney: from
Description
doi: 10.1152/ajpendo.00463.2010 47 DranovskyA.PicchiniA
Di Meco A, Curtis ME, Lauretti E, Pratico D
Araj-Khodaei M, Ayati MH, Azizi Zeinalhajlou A, et al
i.e., a 10-15% lower risk of fractures with GLP-1 RAs
Nat Rev Endocrinol (2020) 16:6156
The FDA has required manufacturers to include pancreatitis warnings in prescribing information for all GLP-1 medications, though the exact causal relationship remains incompletely understood
